nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—OPRM1—telencephalic ventricle—Alzheimer's disease	0.0318	0.233	CbGeAlD
Remifentanil—OPRD1—forebrain—Alzheimer's disease	0.0122	0.0893	CbGeAlD
Remifentanil—OPRK1—forebrain—Alzheimer's disease	0.0117	0.0856	CbGeAlD
Remifentanil—OPRD1—telencephalon—Alzheimer's disease	0.0112	0.0821	CbGeAlD
Remifentanil—OPRM1—forebrain—Alzheimer's disease	0.0083	0.0609	CbGeAlD
Remifentanil—OPRM1—telencephalon—Alzheimer's disease	0.00763	0.056	CbGeAlD
Remifentanil—OPRD1—nervous system—Alzheimer's disease	0.0066	0.0485	CbGeAlD
Remifentanil—OPRD1—central nervous system—Alzheimer's disease	0.00636	0.0467	CbGeAlD
Remifentanil—OPRK1—nervous system—Alzheimer's disease	0.00633	0.0465	CbGeAlD
Remifentanil—OPRK1—central nervous system—Alzheimer's disease	0.0061	0.0447	CbGeAlD
Remifentanil—OPRK1—cerebellum—Alzheimer's disease	0.00596	0.0437	CbGeAlD
Remifentanil—OPRD1—brain—Alzheimer's disease	0.00505	0.0371	CbGeAlD
Remifentanil—Pethidine—GRIN2B—Alzheimer's disease	0.00499	0.625	CrCbGaD
Remifentanil—OPRK1—brain—Alzheimer's disease	0.00484	0.0355	CbGeAlD
Remifentanil—OPRM1—nervous system—Alzheimer's disease	0.0045	0.0331	CbGeAlD
Remifentanil—OPRM1—central nervous system—Alzheimer's disease	0.00434	0.0318	CbGeAlD
Remifentanil—OPRM1—brain—Alzheimer's disease	0.00344	0.0253	CbGeAlD
Remifentanil—Hypokalaemia—Galantamine—Alzheimer's disease	0.00317	0.00414	CcSEcCtD
Remifentanil—Dysphagia—Galantamine—Alzheimer's disease	0.00301	0.00393	CcSEcCtD
Remifentanil—Pulmonary oedema—Memantine—Alzheimer's disease	0.00301	0.00392	CcSEcCtD
Remifentanil—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00294	0.00384	CcSEcCtD
Remifentanil—Bronchitis—Galantamine—Alzheimer's disease	0.0029	0.00378	CcSEcCtD
Remifentanil—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00289	0.00377	CcSEcCtD
Remifentanil—Atrial fibrillation—Donepezil—Alzheimer's disease	0.00285	0.00372	CcSEcCtD
Remifentanil—Sleep disorder—Memantine—Alzheimer's disease	0.00283	0.00369	CcSEcCtD
Remifentanil—Hepatic function abnormal—Memantine—Alzheimer's disease	0.0028	0.00366	CcSEcCtD
Remifentanil—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00277	0.00361	CcSEcCtD
Remifentanil—Disorientation—Memantine—Alzheimer's disease	0.00274	0.00357	CcSEcCtD
Remifentanil—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00272	0.00354	CcSEcCtD
Remifentanil—Pneumonia—Galantamine—Alzheimer's disease	0.0027	0.00352	CcSEcCtD
Remifentanil—Renal failure—Galantamine—Alzheimer's disease	0.00264	0.00344	CcSEcCtD
Remifentanil—Amnesia—Memantine—Alzheimer's disease	0.00261	0.0034	CcSEcCtD
Remifentanil—Atrial fibrillation—Memantine—Alzheimer's disease	0.00259	0.00337	CcSEcCtD
Remifentanil—Renal impairment—Memantine—Alzheimer's disease	0.00258	0.00336	CcSEcCtD
Remifentanil—Urinary retention—Donepezil—Alzheimer's disease	0.00257	0.00335	CcSEcCtD
Remifentanil—Haematuria—Galantamine—Alzheimer's disease	0.00256	0.00334	CcSEcCtD
Remifentanil—Amnesia—Rivastigmine—Alzheimer's disease	0.00255	0.00333	CcSEcCtD
Remifentanil—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.00253	0.0033	CcSEcCtD
Remifentanil—Renal impairment—Rivastigmine—Alzheimer's disease	0.00252	0.00329	CcSEcCtD
Remifentanil—Hypokalaemia—Donepezil—Alzheimer's disease	0.00246	0.00321	CcSEcCtD
Remifentanil—Bradycardia—Galantamine—Alzheimer's disease	0.00245	0.0032	CcSEcCtD
Remifentanil—Haemoglobin—Galantamine—Alzheimer's disease	0.00242	0.00316	CcSEcCtD
Remifentanil—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00241	0.00315	CcSEcCtD
Remifentanil—Haemorrhage—Galantamine—Alzheimer's disease	0.00241	0.00314	CcSEcCtD
Remifentanil—Hallucination—Galantamine—Alzheimer's disease	0.0024	0.00313	CcSEcCtD
Remifentanil—Dysphagia—Donepezil—Alzheimer's disease	0.00233	0.00304	CcSEcCtD
Remifentanil—Urinary retention—Memantine—Alzheimer's disease	0.00233	0.00304	CcSEcCtD
Remifentanil—Cardiac arrest—Memantine—Alzheimer's disease	0.00233	0.00304	CcSEcCtD
Remifentanil—Visual impairment—Galantamine—Alzheimer's disease	0.00232	0.00303	CcSEcCtD
Remifentanil—Urinary retention—Rivastigmine—Alzheimer's disease	0.00228	0.00297	CcSEcCtD
Remifentanil—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00228	0.00297	CcSEcCtD
Remifentanil—Bronchitis—Donepezil—Alzheimer's disease	0.00224	0.00293	CcSEcCtD
Remifentanil—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00224	0.00292	CcSEcCtD
Remifentanil—Cardiac disorder—Galantamine—Alzheimer's disease	0.00224	0.00292	CcSEcCtD
Remifentanil—Flushing—Galantamine—Alzheimer's disease	0.00224	0.00292	CcSEcCtD
Remifentanil—Hypokalaemia—Memantine—Alzheimer's disease	0.00223	0.00291	CcSEcCtD
Remifentanil—Nasopharyngitis—Memantine—Alzheimer's disease	0.00219	0.00286	CcSEcCtD
Remifentanil—Angiopathy—Galantamine—Alzheimer's disease	0.00219	0.00285	CcSEcCtD
Remifentanil—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00218	0.00285	CcSEcCtD
Remifentanil—Dysuria—Donepezil—Alzheimer's disease	0.00218	0.00285	CcSEcCtD
Remifentanil—Immune system disorder—Galantamine—Alzheimer's disease	0.00218	0.00284	CcSEcCtD
Remifentanil—Arrhythmia—Galantamine—Alzheimer's disease	0.00215	0.00281	CcSEcCtD
Remifentanil—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00214	0.0028	CcSEcCtD
Remifentanil—Dysphagia—Memantine—Alzheimer's disease	0.00212	0.00276	CcSEcCtD
Remifentanil—Hyperglycaemia—Donepezil—Alzheimer's disease	0.0021	0.00275	CcSEcCtD
Remifentanil—Pneumonia—Donepezil—Alzheimer's disease	0.00209	0.00273	CcSEcCtD
Remifentanil—Bronchospasm—Memantine—Alzheimer's disease	0.00208	0.00272	CcSEcCtD
Remifentanil—Dysphagia—Rivastigmine—Alzheimer's disease	0.00207	0.0027	CcSEcCtD
Remifentanil—Renal failure—Donepezil—Alzheimer's disease	0.00204	0.00267	CcSEcCtD
Remifentanil—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00204	0.00266	CcSEcCtD
Remifentanil—Bronchitis—Memantine—Alzheimer's disease	0.00204	0.00266	CcSEcCtD
Remifentanil—Sweating—Donepezil—Alzheimer's disease	0.00199	0.0026	CcSEcCtD
Remifentanil—Bronchitis—Rivastigmine—Alzheimer's disease	0.00199	0.0026	CcSEcCtD
Remifentanil—Haematuria—Donepezil—Alzheimer's disease	0.00198	0.00259	CcSEcCtD
Remifentanil—Dysuria—Memantine—Alzheimer's disease	0.00198	0.00258	CcSEcCtD
Remifentanil—Tremor—Galantamine—Alzheimer's disease	0.00197	0.00256	CcSEcCtD
Remifentanil—Anaemia—Galantamine—Alzheimer's disease	0.00194	0.00253	CcSEcCtD
Remifentanil—Dysuria—Rivastigmine—Alzheimer's disease	0.00194	0.00253	CcSEcCtD
Remifentanil—Agitation—Galantamine—Alzheimer's disease	0.00193	0.00251	CcSEcCtD
Remifentanil—Hyperglycaemia—Memantine—Alzheimer's disease	0.00191	0.00249	CcSEcCtD
Remifentanil—Bradycardia—Donepezil—Alzheimer's disease	0.0019	0.00248	CcSEcCtD
Remifentanil—Pneumonia—Memantine—Alzheimer's disease	0.0019	0.00248	CcSEcCtD
Remifentanil—Syncope—Galantamine—Alzheimer's disease	0.00188	0.00245	CcSEcCtD
Remifentanil—Haemoglobin—Donepezil—Alzheimer's disease	0.00188	0.00245	CcSEcCtD
Remifentanil—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00187	0.00244	CcSEcCtD
Remifentanil—Haemorrhage—Donepezil—Alzheimer's disease	0.00187	0.00244	CcSEcCtD
Remifentanil—Pneumonia—Rivastigmine—Alzheimer's disease	0.00186	0.00242	CcSEcCtD
Remifentanil—Hallucination—Donepezil—Alzheimer's disease	0.00186	0.00242	CcSEcCtD
Remifentanil—Renal failure—Memantine—Alzheimer's disease	0.00186	0.00242	CcSEcCtD
Remifentanil—Pharyngitis—Donepezil—Alzheimer's disease	0.00185	0.00242	CcSEcCtD
Remifentanil—Loss of consciousness—Galantamine—Alzheimer's disease	0.00184	0.00241	CcSEcCtD
Remifentanil—Cough—Galantamine—Alzheimer's disease	0.00183	0.00239	CcSEcCtD
Remifentanil—Convulsion—Galantamine—Alzheimer's disease	0.00182	0.00237	CcSEcCtD
Remifentanil—Renal failure—Rivastigmine—Alzheimer's disease	0.00182	0.00237	CcSEcCtD
Remifentanil—Hypertension—Galantamine—Alzheimer's disease	0.00181	0.00236	CcSEcCtD
Remifentanil—Haematuria—Memantine—Alzheimer's disease	0.0018	0.00235	CcSEcCtD
Remifentanil—Visual impairment—Donepezil—Alzheimer's disease	0.0018	0.00235	CcSEcCtD
Remifentanil—Anxiety—Galantamine—Alzheimer's disease	0.00178	0.00232	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00177	0.00231	CcSEcCtD
Remifentanil—Sweating—Rivastigmine—Alzheimer's disease	0.00177	0.00231	CcSEcCtD
Remifentanil—Haematuria—Rivastigmine—Alzheimer's disease	0.00176	0.0023	CcSEcCtD
Remifentanil—Pethidine—SLC6A4—Alzheimer's disease	0.00176	0.221	CrCbGaD
Remifentanil—Dry mouth—Galantamine—Alzheimer's disease	0.00175	0.00228	CcSEcCtD
Remifentanil—Confusional state—Galantamine—Alzheimer's disease	0.00173	0.00225	CcSEcCtD
Remifentanil—Bradycardia—Memantine—Alzheimer's disease	0.00173	0.00225	CcSEcCtD
Remifentanil—Haemoglobin—Memantine—Alzheimer's disease	0.0017	0.00222	CcSEcCtD
Remifentanil—Haemorrhage—Memantine—Alzheimer's disease	0.0017	0.00221	CcSEcCtD
Remifentanil—Bradycardia—Rivastigmine—Alzheimer's disease	0.00169	0.0022	CcSEcCtD
Remifentanil—Hallucination—Memantine—Alzheimer's disease	0.00169	0.0022	CcSEcCtD
Remifentanil—Shock—Galantamine—Alzheimer's disease	0.00168	0.0022	CcSEcCtD
Remifentanil—Pharyngitis—Memantine—Alzheimer's disease	0.00168	0.0022	CcSEcCtD
Remifentanil—Nervous system disorder—Galantamine—Alzheimer's disease	0.00168	0.00219	CcSEcCtD
Remifentanil—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00168	0.00219	CcSEcCtD
Remifentanil—Chills—Donepezil—Alzheimer's disease	0.00168	0.00219	CcSEcCtD
Remifentanil—Tachycardia—Galantamine—Alzheimer's disease	0.00167	0.00218	CcSEcCtD
Remifentanil—Arrhythmia—Donepezil—Alzheimer's disease	0.00167	0.00218	CcSEcCtD
Remifentanil—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00167	0.00218	CcSEcCtD
Remifentanil—Skin disorder—Galantamine—Alzheimer's disease	0.00166	0.00217	CcSEcCtD
Remifentanil—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00166	0.00216	CcSEcCtD
Remifentanil—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00165	0.00216	CcSEcCtD
Remifentanil—Hallucination—Rivastigmine—Alzheimer's disease	0.00165	0.00215	CcSEcCtD
Remifentanil—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00165	0.00215	CcSEcCtD
Remifentanil—Visual impairment—Memantine—Alzheimer's disease	0.00163	0.00213	CcSEcCtD
Remifentanil—Erythema—Donepezil—Alzheimer's disease	0.00163	0.00212	CcSEcCtD
Remifentanil—Hypotension—Galantamine—Alzheimer's disease	0.0016	0.00209	CcSEcCtD
Remifentanil—Visual impairment—Rivastigmine—Alzheimer's disease	0.0016	0.00209	CcSEcCtD
Remifentanil—Cardiac disorder—Memantine—Alzheimer's disease	0.00157	0.00205	CcSEcCtD
Remifentanil—Flushing—Memantine—Alzheimer's disease	0.00157	0.00205	CcSEcCtD
Remifentanil—Flushing—Rivastigmine—Alzheimer's disease	0.00154	0.00201	CcSEcCtD
Remifentanil—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00154	0.00201	CcSEcCtD
Remifentanil—Angiopathy—Memantine—Alzheimer's disease	0.00154	0.00201	CcSEcCtD
Remifentanil—Paraesthesia—Galantamine—Alzheimer's disease	0.00154	0.00201	CcSEcCtD
Remifentanil—Immune system disorder—Memantine—Alzheimer's disease	0.00153	0.002	CcSEcCtD
Remifentanil—Mediastinal disorder—Memantine—Alzheimer's disease	0.00153	0.00199	CcSEcCtD
Remifentanil—Tremor—Donepezil—Alzheimer's disease	0.00152	0.00199	CcSEcCtD
Remifentanil—Somnolence—Galantamine—Alzheimer's disease	0.00152	0.00199	CcSEcCtD
Remifentanil—Chills—Memantine—Alzheimer's disease	0.00152	0.00198	CcSEcCtD
Remifentanil—Arrhythmia—Memantine—Alzheimer's disease	0.00151	0.00198	CcSEcCtD
Remifentanil—Dyspepsia—Galantamine—Alzheimer's disease	0.00151	0.00197	CcSEcCtD
Remifentanil—Angiopathy—Rivastigmine—Alzheimer's disease	0.0015	0.00196	CcSEcCtD
Remifentanil—Anaemia—Donepezil—Alzheimer's disease	0.0015	0.00196	CcSEcCtD
Remifentanil—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00149	0.00195	CcSEcCtD
Remifentanil—Agitation—Donepezil—Alzheimer's disease	0.00149	0.00195	CcSEcCtD
Remifentanil—Chills—Rivastigmine—Alzheimer's disease	0.00149	0.00194	CcSEcCtD
Remifentanil—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00148	0.00193	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00148	0.00193	CcSEcCtD
Remifentanil—Constipation—Galantamine—Alzheimer's disease	0.00146	0.00191	CcSEcCtD
Remifentanil—Syncope—Donepezil—Alzheimer's disease	0.00146	0.0019	CcSEcCtD
Remifentanil—Erythema—Rivastigmine—Alzheimer's disease	0.00144	0.00188	CcSEcCtD
Remifentanil—Loss of consciousness—Donepezil—Alzheimer's disease	0.00143	0.00186	CcSEcCtD
Remifentanil—Cough—Donepezil—Alzheimer's disease	0.00142	0.00185	CcSEcCtD
Remifentanil—Feeling abnormal—Galantamine—Alzheimer's disease	0.00141	0.00184	CcSEcCtD
Remifentanil—Convulsion—Donepezil—Alzheimer's disease	0.00141	0.00184	CcSEcCtD
Remifentanil—Hypertension—Donepezil—Alzheimer's disease	0.0014	0.00183	CcSEcCtD
Remifentanil—Tremor—Memantine—Alzheimer's disease	0.00138	0.0018	CcSEcCtD
Remifentanil—Anxiety—Donepezil—Alzheimer's disease	0.00138	0.0018	CcSEcCtD
Remifentanil—Anaemia—Memantine—Alzheimer's disease	0.00136	0.00178	CcSEcCtD
Remifentanil—Agitation—Memantine—Alzheimer's disease	0.00136	0.00177	CcSEcCtD
Remifentanil—Dry mouth—Donepezil—Alzheimer's disease	0.00135	0.00177	CcSEcCtD
Remifentanil—Body temperature increased—Galantamine—Alzheimer's disease	0.00135	0.00177	CcSEcCtD
Remifentanil—Tremor—Rivastigmine—Alzheimer's disease	0.00135	0.00176	CcSEcCtD
Remifentanil—Confusional state—Donepezil—Alzheimer's disease	0.00134	0.00175	CcSEcCtD
Remifentanil—Anaemia—Rivastigmine—Alzheimer's disease	0.00133	0.00174	CcSEcCtD
Remifentanil—Agitation—Rivastigmine—Alzheimer's disease	0.00133	0.00173	CcSEcCtD
Remifentanil—Oedema—Donepezil—Alzheimer's disease	0.00133	0.00173	CcSEcCtD
Remifentanil—Syncope—Memantine—Alzheimer's disease	0.00132	0.00173	CcSEcCtD
Remifentanil—Shock—Donepezil—Alzheimer's disease	0.00131	0.0017	CcSEcCtD
Remifentanil—Nervous system disorder—Donepezil—Alzheimer's disease	0.0013	0.0017	CcSEcCtD
Remifentanil—Thrombocytopenia—Donepezil—Alzheimer's disease	0.0013	0.00169	CcSEcCtD
Remifentanil—Loss of consciousness—Memantine—Alzheimer's disease	0.0013	0.00169	CcSEcCtD
Remifentanil—Syncope—Rivastigmine—Alzheimer's disease	0.00129	0.00169	CcSEcCtD
Remifentanil—Cough—Memantine—Alzheimer's disease	0.00129	0.00168	CcSEcCtD
Remifentanil—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00128	0.00167	CcSEcCtD
Remifentanil—Convulsion—Memantine—Alzheimer's disease	0.00128	0.00167	CcSEcCtD
Remifentanil—Hypertension—Memantine—Alzheimer's disease	0.00127	0.00166	CcSEcCtD
Remifentanil—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00127	0.00166	CcSEcCtD
Remifentanil—Hypersensitivity—Galantamine—Alzheimer's disease	0.00126	0.00165	CcSEcCtD
Remifentanil—Cough—Rivastigmine—Alzheimer's disease	0.00126	0.00164	CcSEcCtD
Remifentanil—Anxiety—Memantine—Alzheimer's disease	0.00125	0.00163	CcSEcCtD
Remifentanil—Convulsion—Rivastigmine—Alzheimer's disease	0.00125	0.00163	CcSEcCtD
Remifentanil—Hypertension—Rivastigmine—Alzheimer's disease	0.00125	0.00163	CcSEcCtD
Remifentanil—Hypotension—Donepezil—Alzheimer's disease	0.00124	0.00162	CcSEcCtD
Remifentanil—Pethidine—CYP2D6—Alzheimer's disease	0.00124	0.155	CrCbGaD
Remifentanil—Dry mouth—Memantine—Alzheimer's disease	0.00123	0.0016	CcSEcCtD
Remifentanil—Anxiety—Rivastigmine—Alzheimer's disease	0.00123	0.0016	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00122	0.00159	CcSEcCtD
Remifentanil—Confusional state—Memantine—Alzheimer's disease	0.00121	0.00158	CcSEcCtD
Remifentanil—Oedema—Memantine—Alzheimer's disease	0.0012	0.00157	CcSEcCtD
Remifentanil—Dry mouth—Rivastigmine—Alzheimer's disease	0.0012	0.00157	CcSEcCtD
Remifentanil—Paraesthesia—Donepezil—Alzheimer's disease	0.00119	0.00155	CcSEcCtD
Remifentanil—Confusional state—Rivastigmine—Alzheimer's disease	0.00119	0.00155	CcSEcCtD
Remifentanil—Shock—Memantine—Alzheimer's disease	0.00119	0.00155	CcSEcCtD
Remifentanil—Dyspnoea—Donepezil—Alzheimer's disease	0.00118	0.00154	CcSEcCtD
Remifentanil—Nervous system disorder—Memantine—Alzheimer's disease	0.00118	0.00154	CcSEcCtD
Remifentanil—Somnolence—Donepezil—Alzheimer's disease	0.00118	0.00154	CcSEcCtD
Remifentanil—Thrombocytopenia—Memantine—Alzheimer's disease	0.00118	0.00154	CcSEcCtD
Remifentanil—Oedema—Rivastigmine—Alzheimer's disease	0.00118	0.00154	CcSEcCtD
Remifentanil—Tachycardia—Memantine—Alzheimer's disease	0.00118	0.00153	CcSEcCtD
Remifentanil—Diarrhoea—Galantamine—Alzheimer's disease	0.00117	0.00153	CcSEcCtD
Remifentanil—Skin disorder—Memantine—Alzheimer's disease	0.00117	0.00153	CcSEcCtD
Remifentanil—Dyspepsia—Donepezil—Alzheimer's disease	0.00117	0.00152	CcSEcCtD
Remifentanil—Hyperhidrosis—Memantine—Alzheimer's disease	0.00116	0.00152	CcSEcCtD
Remifentanil—Shock—Rivastigmine—Alzheimer's disease	0.00116	0.00151	CcSEcCtD
Remifentanil—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00116	0.00151	CcSEcCtD
Remifentanil—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00115	0.00151	CcSEcCtD
Remifentanil—Tachycardia—Rivastigmine—Alzheimer's disease	0.00115	0.0015	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00115	0.00149	CcSEcCtD
Remifentanil—Skin disorder—Rivastigmine—Alzheimer's disease	0.00114	0.00149	CcSEcCtD
Remifentanil—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00114	0.00149	CcSEcCtD
Remifentanil—Pain—Donepezil—Alzheimer's disease	0.00113	0.00148	CcSEcCtD
Remifentanil—Constipation—Donepezil—Alzheimer's disease	0.00113	0.00148	CcSEcCtD
Remifentanil—Dizziness—Galantamine—Alzheimer's disease	0.00113	0.00148	CcSEcCtD
Remifentanil—Hypotension—Memantine—Alzheimer's disease	0.00113	0.00147	CcSEcCtD
Remifentanil—Hypotension—Rivastigmine—Alzheimer's disease	0.0011	0.00144	CcSEcCtD
Remifentanil—Feeling abnormal—Donepezil—Alzheimer's disease	0.00109	0.00143	CcSEcCtD
Remifentanil—Vomiting—Galantamine—Alzheimer's disease	0.00109	0.00142	CcSEcCtD
Remifentanil—Paraesthesia—Memantine—Alzheimer's disease	0.00108	0.00141	CcSEcCtD
Remifentanil—Rash—Galantamine—Alzheimer's disease	0.00108	0.00141	CcSEcCtD
Remifentanil—Dermatitis—Galantamine—Alzheimer's disease	0.00108	0.00141	CcSEcCtD
Remifentanil—Dyspnoea—Memantine—Alzheimer's disease	0.00107	0.0014	CcSEcCtD
Remifentanil—Headache—Galantamine—Alzheimer's disease	0.00107	0.0014	CcSEcCtD
Remifentanil—Somnolence—Memantine—Alzheimer's disease	0.00107	0.0014	CcSEcCtD
Remifentanil—Dyspepsia—Memantine—Alzheimer's disease	0.00106	0.00138	CcSEcCtD
Remifentanil—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00106	0.00138	CcSEcCtD
Remifentanil—Urticaria—Donepezil—Alzheimer's disease	0.00105	0.00138	CcSEcCtD
Remifentanil—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00105	0.00137	CcSEcCtD
Remifentanil—Body temperature increased—Donepezil—Alzheimer's disease	0.00105	0.00137	CcSEcCtD
Remifentanil—Somnolence—Rivastigmine—Alzheimer's disease	0.00105	0.00137	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00104	0.00136	CcSEcCtD
Remifentanil—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00104	0.00135	CcSEcCtD
Remifentanil—Constipation—Memantine—Alzheimer's disease	0.00103	0.00134	CcSEcCtD
Remifentanil—Pain—Memantine—Alzheimer's disease	0.00103	0.00134	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00102	0.00133	CcSEcCtD
Remifentanil—Nausea—Galantamine—Alzheimer's disease	0.00102	0.00133	CcSEcCtD
Remifentanil—Pain—Rivastigmine—Alzheimer's disease	0.00101	0.00131	CcSEcCtD
Remifentanil—Constipation—Rivastigmine—Alzheimer's disease	0.00101	0.00131	CcSEcCtD
Remifentanil—Feeling abnormal—Memantine—Alzheimer's disease	0.000993	0.0013	CcSEcCtD
Remifentanil—Hypersensitivity—Donepezil—Alzheimer's disease	0.000977	0.00128	CcSEcCtD
Remifentanil—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000971	0.00127	CcSEcCtD
Remifentanil—Urticaria—Memantine—Alzheimer's disease	0.000957	0.00125	CcSEcCtD
Remifentanil—Body temperature increased—Memantine—Alzheimer's disease	0.000952	0.00124	CcSEcCtD
Remifentanil—Pruritus—Donepezil—Alzheimer's disease	0.000939	0.00122	CcSEcCtD
Remifentanil—Urticaria—Rivastigmine—Alzheimer's disease	0.000936	0.00122	CcSEcCtD
Remifentanil—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000932	0.00122	CcSEcCtD
Remifentanil—Diarrhoea—Donepezil—Alzheimer's disease	0.000908	0.00118	CcSEcCtD
Remifentanil—Hypersensitivity—Memantine—Alzheimer's disease	0.000888	0.00116	CcSEcCtD
Remifentanil—Dizziness—Donepezil—Alzheimer's disease	0.000877	0.00114	CcSEcCtD
Remifentanil—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000868	0.00113	CcSEcCtD
Remifentanil—Pruritus—Memantine—Alzheimer's disease	0.000852	0.00111	CcSEcCtD
Remifentanil—Vomiting—Donepezil—Alzheimer's disease	0.000844	0.0011	CcSEcCtD
Remifentanil—Rash—Donepezil—Alzheimer's disease	0.000837	0.00109	CcSEcCtD
Remifentanil—Dermatitis—Donepezil—Alzheimer's disease	0.000836	0.00109	CcSEcCtD
Remifentanil—Pruritus—Rivastigmine—Alzheimer's disease	0.000834	0.00109	CcSEcCtD
Remifentanil—Headache—Donepezil—Alzheimer's disease	0.000831	0.00108	CcSEcCtD
Remifentanil—Diarrhoea—Memantine—Alzheimer's disease	0.000824	0.00108	CcSEcCtD
Remifentanil—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000806	0.00105	CcSEcCtD
Remifentanil—Dizziness—Memantine—Alzheimer's disease	0.000797	0.00104	CcSEcCtD
Remifentanil—Nausea—Donepezil—Alzheimer's disease	0.000788	0.00103	CcSEcCtD
Remifentanil—Dizziness—Rivastigmine—Alzheimer's disease	0.000779	0.00102	CcSEcCtD
Remifentanil—Vomiting—Memantine—Alzheimer's disease	0.000766	0.000999	CcSEcCtD
Remifentanil—Rash—Memantine—Alzheimer's disease	0.00076	0.000991	CcSEcCtD
Remifentanil—Dermatitis—Memantine—Alzheimer's disease	0.000759	0.00099	CcSEcCtD
Remifentanil—Headache—Memantine—Alzheimer's disease	0.000755	0.000985	CcSEcCtD
Remifentanil—Vomiting—Rivastigmine—Alzheimer's disease	0.000749	0.000978	CcSEcCtD
Remifentanil—Rash—Rivastigmine—Alzheimer's disease	0.000743	0.000969	CcSEcCtD
Remifentanil—Dermatitis—Rivastigmine—Alzheimer's disease	0.000742	0.000969	CcSEcCtD
Remifentanil—Headache—Rivastigmine—Alzheimer's disease	0.000738	0.000963	CcSEcCtD
Remifentanil—Nausea—Memantine—Alzheimer's disease	0.000716	0.000934	CcSEcCtD
Remifentanil—Nausea—Rivastigmine—Alzheimer's disease	0.0007	0.000913	CcSEcCtD
Remifentanil—OPRM1—Signaling Pathways—TTR—Alzheimer's disease	0.000149	0.00167	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000148	0.00166	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—NPS—Alzheimer's disease	0.000148	0.00166	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000147	0.00165	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR6—Alzheimer's disease	0.000147	0.00164	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—AKT1—Alzheimer's disease	0.000147	0.00164	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000143	0.0016	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000143	0.0016	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—NPY—Alzheimer's disease	0.000142	0.00159	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000141	0.00158	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—SST—Alzheimer's disease	0.000141	0.00158	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000141	0.00158	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—APP—Alzheimer's disease	0.000138	0.00154	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CRH—Alzheimer's disease	0.000137	0.00153	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—SST—Alzheimer's disease	0.000136	0.00153	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000136	0.00153	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CCL2—Alzheimer's disease	0.000136	0.00152	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDK5—Alzheimer's disease	0.000134	0.0015	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—F2—Alzheimer's disease	0.000133	0.00149	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PSENEN—Alzheimer's disease	0.000133	0.00149	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—APP—Alzheimer's disease	0.000133	0.00149	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—NPY—Alzheimer's disease	0.000132	0.00148	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000132	0.00148	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCR5—Alzheimer's disease	0.000131	0.00147	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000131	0.00147	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APH1A—Alzheimer's disease	0.000131	0.00147	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PYY—Alzheimer's disease	0.00013	0.00146	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.00013	0.00145	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—NPS—Alzheimer's disease	0.00013	0.00145	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000129	0.00145	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000129	0.00144	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR6—Alzheimer's disease	0.000129	0.00144	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000128	0.00143	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CRH—Alzheimer's disease	0.000127	0.00143	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000125	0.0014	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LRP1—Alzheimer's disease	0.000125	0.0014	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—SST—Alzheimer's disease	0.000124	0.00139	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000124	0.00139	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GAL—Alzheimer's disease	0.000122	0.00136	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GFAP—Alzheimer's disease	0.000122	0.00136	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000121	0.00135	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—APP—Alzheimer's disease	0.000121	0.00135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—NPY—Alzheimer's disease	0.00012	0.00134	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000119	0.00134	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCL2—Alzheimer's disease	0.000119	0.00133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PSENEN—Alzheimer's disease	0.000117	0.00131	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CRH—Alzheimer's disease	0.000116	0.0013	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—SST—Alzheimer's disease	0.000115	0.00129	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000115	0.00129	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APH1A—Alzheimer's disease	0.000115	0.00129	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000114	0.00128	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDK5—Alzheimer's disease	0.000113	0.00126	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—F2—Alzheimer's disease	0.000113	0.00126	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—APP—Alzheimer's disease	0.000112	0.00126	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000112	0.00126	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—NPS—Alzheimer's disease	0.00011	0.00123	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LRP1—Alzheimer's disease	0.000109	0.00122	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000109	0.00122	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR6—Alzheimer's disease	0.000109	0.00122	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—A2M—Alzheimer's disease	0.000107	0.0012	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GFAP—Alzheimer's disease	0.000107	0.0012	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GAL—Alzheimer's disease	0.000107	0.0012	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000106	0.00119	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000106	0.00118	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—SST—Alzheimer's disease	0.000105	0.00117	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000105	0.00117	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000104	0.00116	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—APP—Alzheimer's disease	0.000102	0.00114	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL2—Alzheimer's disease	0.0001	0.00113	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.0001	0.00112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PSENEN—Alzheimer's disease	9.86e-05	0.0011	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.81e-05	0.0011	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APH1A—Alzheimer's disease	9.73e-05	0.00109	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	9.62e-05	0.00108	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PRKCG—Alzheimer's disease	9.6e-05	0.00108	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NPY—Alzheimer's disease	9.56e-05	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IAPP—Alzheimer's disease	9.5e-05	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NCSTN—Alzheimer's disease	9.47e-05	0.00106	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—A2M—Alzheimer's disease	9.41e-05	0.00105	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.27e-05	0.00104	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LRP1—Alzheimer's disease	9.24e-05	0.00103	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CRH—Alzheimer's disease	9.22e-05	0.00103	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PSEN2—Alzheimer's disease	9.11e-05	0.00102	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR5—Alzheimer's disease	9.1e-05	0.00102	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GAL—Alzheimer's disease	9.02e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GFAP—Alzheimer's disease	9.02e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR2A—Alzheimer's disease	8.91e-05	0.000998	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR5—Alzheimer's disease	8.79e-05	0.000984	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NPS—Alzheimer's disease	8.74e-05	0.00098	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PPP3CA—Alzheimer's disease	8.7e-05	0.000975	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.6e-05	0.000963	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—F2—Alzheimer's disease	8.6e-05	0.000963	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTK2B—Alzheimer's disease	8.58e-05	0.000961	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PRKCG—Alzheimer's disease	8.42e-05	0.000943	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NPY—Alzheimer's disease	8.38e-05	0.000939	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GAB2—Alzheimer's disease	8.34e-05	0.000935	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SST—Alzheimer's disease	8.34e-05	0.000935	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NTRK2—Alzheimer's disease	8.34e-05	0.000935	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IAPP—Alzheimer's disease	8.33e-05	0.000933	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CALM1—Alzheimer's disease	8.31e-05	0.000931	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GSK3A—Alzheimer's disease	8.27e-05	0.000926	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APP—Alzheimer's disease	8.13e-05	0.000911	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CRH—Alzheimer's disease	8.09e-05	0.000906	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR5—Alzheimer's disease	7.98e-05	0.000894	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—A2M—Alzheimer's disease	7.95e-05	0.000891	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.84e-05	0.000878	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR2A—Alzheimer's disease	7.81e-05	0.000875	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—F2—Alzheimer's disease	7.81e-05	0.000875	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PSEN2—Alzheimer's disease	7.7e-05	0.000863	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PLCB1—Alzheimer's disease	7.67e-05	0.000859	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NPS—Alzheimer's disease	7.67e-05	0.000859	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PPP3CA—Alzheimer's disease	7.63e-05	0.000855	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—F2—Alzheimer's disease	7.54e-05	0.000845	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTK2B—Alzheimer's disease	7.52e-05	0.000842	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	7.43e-05	0.000832	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GAB2—Alzheimer's disease	7.32e-05	0.000819	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SST—Alzheimer's disease	7.32e-05	0.000819	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NTRK2—Alzheimer's disease	7.32e-05	0.000819	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CALM1—Alzheimer's disease	7.29e-05	0.000816	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.27e-05	0.000814	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GSK3A—Alzheimer's disease	7.25e-05	0.000812	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NGFR—Alzheimer's disease	7.16e-05	0.000802	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APP—Alzheimer's disease	7.13e-05	0.000799	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	7.12e-05	0.000797	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CREB1—Alzheimer's disease	7.11e-05	0.000797	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NPY—Alzheimer's disease	7.09e-05	0.000794	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IAPP—Alzheimer's disease	7.04e-05	0.000789	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADAM10—Alzheimer's disease	6.99e-05	0.000783	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL2—Alzheimer's disease	6.96e-05	0.00078	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—F2—Alzheimer's disease	6.85e-05	0.000767	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CRH—Alzheimer's disease	6.84e-05	0.000766	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR5—Alzheimer's disease	6.74e-05	0.000755	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLCB1—Alzheimer's disease	6.73e-05	0.000754	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—S100B—Alzheimer's disease	6.61e-05	0.000741	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	6.6e-05	0.000739	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NPS—Alzheimer's disease	6.48e-05	0.000726	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	6.45e-05	0.000722	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—F2—Alzheimer's disease	6.37e-05	0.000714	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTK2B—Alzheimer's disease	6.36e-05	0.000712	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF2—Alzheimer's disease	6.29e-05	0.000705	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NGFR—Alzheimer's disease	6.28e-05	0.000703	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CREB1—Alzheimer's disease	6.24e-05	0.000699	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SST—Alzheimer's disease	6.18e-05	0.000693	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NTRK2—Alzheimer's disease	6.18e-05	0.000693	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GAB2—Alzheimer's disease	6.18e-05	0.000693	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CALM1—Alzheimer's disease	6.16e-05	0.00069	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADAM10—Alzheimer's disease	6.13e-05	0.000687	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GSK3A—Alzheimer's disease	6.13e-05	0.000687	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL2—Alzheimer's disease	6.1e-05	0.000684	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1R—Alzheimer's disease	6.09e-05	0.000682	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APP—Alzheimer's disease	6.02e-05	0.000675	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LPL—Alzheimer's disease	5.83e-05	0.000654	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—S100B—Alzheimer's disease	5.8e-05	0.000649	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—F2—Alzheimer's disease	5.79e-05	0.000648	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MEF2C—Alzheimer's disease	5.78e-05	0.000648	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLCB1—Alzheimer's disease	5.68e-05	0.000637	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCG—Alzheimer's disease	5.67e-05	0.000636	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NGF—Alzheimer's disease	5.53e-05	0.000619	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF2—Alzheimer's disease	5.52e-05	0.000618	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR5—Alzheimer's disease	5.38e-05	0.000602	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1R—Alzheimer's disease	5.34e-05	0.000598	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	5.3e-05	0.000594	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	5.27e-05	0.00059	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2A—Alzheimer's disease	5.26e-05	0.000589	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	5.18e-05	0.00058	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	5.16e-05	0.000578	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LPL—Alzheimer's disease	5.12e-05	0.000573	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MEF2C—Alzheimer's disease	5.07e-05	0.000568	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCG—Alzheimer's disease	4.97e-05	0.000557	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CALM1—Alzheimer's disease	4.91e-05	0.00055	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	4.9e-05	0.000549	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOE—Alzheimer's disease	4.89e-05	0.000548	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LEP—Alzheimer's disease	4.89e-05	0.000548	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CAV1—Alzheimer's disease	4.85e-05	0.000543	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NGF—Alzheimer's disease	4.85e-05	0.000543	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR5—Alzheimer's disease	4.71e-05	0.000528	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ESR1—Alzheimer's disease	4.67e-05	0.000523	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	4.66e-05	0.000523	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2A—Alzheimer's disease	4.61e-05	0.000517	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—F2—Alzheimer's disease	4.61e-05	0.000517	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.51e-05	0.000506	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	4.51e-05	0.000505	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	4.32e-05	0.000484	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CALM1—Alzheimer's disease	4.3e-05	0.000482	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LEP—Alzheimer's disease	4.29e-05	0.00048	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOE—Alzheimer's disease	4.29e-05	0.00048	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	4.29e-05	0.00048	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CAV1—Alzheimer's disease	4.25e-05	0.000476	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GSK3B—Alzheimer's disease	4.24e-05	0.000474	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	4.2e-05	0.000471	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CREB1—Alzheimer's disease	4.2e-05	0.000471	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INS—Alzheimer's disease	4.18e-05	0.000468	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL2—Alzheimer's disease	4.11e-05	0.000461	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	4.1e-05	0.000459	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ESR1—Alzheimer's disease	4.09e-05	0.000459	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—F2—Alzheimer's disease	4.04e-05	0.000453	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1—Alzheimer's disease	4.04e-05	0.000453	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	3.98e-05	0.000446	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.96e-05	0.000443	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	3.9e-05	0.000437	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	3.71e-05	0.000416	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	3.68e-05	0.000413	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	3.66e-05	0.00041	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INS—Alzheimer's disease	3.66e-05	0.00041	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	3.64e-05	0.000407	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	3.62e-05	0.000406	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	3.62e-05	0.000406	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	3.6e-05	0.000404	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	3.59e-05	0.000402	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	3.54e-05	0.000397	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	3.46e-05	0.000388	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—F2—Alzheimer's disease	3.42e-05	0.000383	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.34e-05	0.000375	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	3.21e-05	0.00036	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.14e-05	0.000352	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	3.14e-05	0.000352	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	3.11e-05	0.000349	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	3.11e-05	0.000348	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INS—Alzheimer's disease	3.1e-05	0.000347	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	3.09e-05	0.000346	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	3.05e-05	0.000341	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.99e-05	0.000336	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.86e-05	0.00032	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.85e-05	0.000319	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.75e-05	0.000308	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	2.73e-05	0.000306	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.72e-05	0.000304	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	2.71e-05	0.000304	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	2.64e-05	0.000296	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	2.51e-05	0.000281	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	2.5e-05	0.00028	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	2.42e-05	0.000271	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.33e-05	0.000261	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	2.31e-05	0.000259	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	2.31e-05	0.000258	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	2.29e-05	0.000257	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	2.12e-05	0.000238	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.12e-05	0.000237	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.11e-05	0.000237	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	1.99e-05	0.000223	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.96e-05	0.000219	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	1.83e-05	0.000205	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.8e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	1.75e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.68e-05	0.000189	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	1.6e-05	0.000179	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	1.48e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	1.48e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	1.35e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.25e-05	0.00014	CbGpPWpGaD
